
Please click here to read the full story.

Please click here to read the full story.

Please click here to read the full story.

Please click here to read the full story.

Avastin (bevacizumab; Genentech) increases the ease of vitrectomy in severe proliferative diabetic retinopathy (PDR), according to a study published in the July issue of Clinical and Experimental Ophthalmology.

Please click here to read the full story.

The lack of experience with evidence-based guidelines may be the reason for excessive follow-up after screening for hydroxychloroquine retinopathy, according to study results published in the December issue of the British Journal of Ophthalmology.

The BD range of Atomic Edge Limbal Relaxing Incision (LRI) knives for surgical correction of astigmatism has been launched by BD Medical. The knives, which feature a retractable safety shield, use single-crystal silicon, offering high performance at low cost.

Topical nepafenac as a treatment for CME

The Pascal dynamic contour tonometer (DCT) and Reichert ocular response analyser (ORA) are the best tools for measuring corneal-compensated intraocular pressure (IOPcc) in patients with keratoconus (KC), according to study results published in the British Journal of Ophthalmology, December.

When using bevacizumab to treat choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), a loading dose (LD) of bevacizumab is more effective than an as-needed (PRN) dosing schedule, according to study results published in the December issue of the British Journal of Ophthalmology.

Biaxial microincision cataract surgery (B-MICS) is more successful than traditional cataract surgery in improving optical performance and reducing higher order aberrations, according to study results published in the December issue of the British Journal of Ophthalmology.

PDT and ranibizumab combination therapy results

Bevacizumab and glaucoma changes

Pegaptanib sodium therapy is safe in patients with neovascular age-related macular degeneration (NV-AMD) up to three years, according to study results published in the December issue of the British Journal of Ophthalmology.

Endophthalmitis incidence after intravitreal injections

Trabeculectomy with or without MMC: 9-year data

Views of glaucoma patients on provision of follow-up care

Paediatric strabismus, particularly exotropia, increases the likelihood of psychiatric disease in later life, according to study results published in the November issue of Pediatrics.

Keratoconus diagnosis with OCT

A multimedia campaign may be the best way to raise glaucoma awareness in the UK, according to study results published in the December issue of the British Journal of Ophthalmology.

Dynamic stimulation of accommodation

It is possible to administer verteporfin and ranibizumab on the same day without adverse events, according to study results published in the December issue of the British Journal of Ophthalmology.

Changes in wavefront aberrations in MICS

Highlights from the 2008 meeting of the American Academy of Ophthalmology (AAO)

I do not believe that safe and effective SBK can be performed with a microkeratome.

STAAR Surgical has created the Collamer Accommodating Study Team (CAST), a group of seven ophthalmologists who will investigate the accommodative properties of STAAR's Collamer intraocular lens (IOL).

It is up to our refractive surgery colleagues to publish their results on such patients to allow us to put some, or all, of our questions to rest.

All the latest product news and developments, December 2008

Although 25 G sutureless vitrectomy has increased in popularity, it is associated with postoperative complications including hypotony, choroidal detachment, and endophthalmitis. Richard Kaiser, MD, from the Retina Service of Wills Eye Institute, Philadelphia, noted that the 25 G procedure has a 12.4 times greater risk of endophthalmitis when compared with the 20 G procedure.

Three-year results from the Tube versus Trabeculectomy Study showed that tube-shunt surgery was more likely than trabeculectomy with mitomycin C to maintain IOP control and avoid persistent hypotony, loss of light perception vision, or re-operation for glaucoma.